{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:00:06Z","timestamp":1783044006746,"version":"3.54.6"},"reference-count":36,"publisher":"Impact Journals, LLC","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,2,9]]},"DOI":"10.18632\/oncotarget.6880","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T12:36:48Z","timestamp":1452515808000},"page":"7149-7160","source":"Crossref","is-referenced-by-count":26,"title":["miRNA-29a as a tumor suppressor mediates PRIMA-1Met-induced anti-myeloma activity by targeting c-Myc"],"prefix":"10.18632","volume":"7","author":[{"given":"Manujendra N.","family":"Saha","sequence":"first","affiliation":[{"name":"Division of Molecular and Cellular Biology, Toronto General Research Institute, Toronto, Ontario, Canada"},{"name":"Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahangir","family":"Abdi","sequence":"additional","affiliation":[{"name":"Division of Molecular and Cellular Biology, Toronto General Research Institute, Toronto, Ontario, Canada"},{"name":"Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Molecular and Cellular Biology, Toronto General Research Institute, Toronto, Ontario, Canada"},{"name":"Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Applied Chemistry, School of Chemical Engineering and Technology, Tianjin University, Tianjin, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Molecular and Cellular Biology, Toronto General Research Institute, Toronto, Ontario, Canada"},{"name":"Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Laboratory Hematology and Medical Oncology, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,1,11]]},"reference":[{"key":"1","first-page":"248","article-title":"Advances in biology and therapy of multiple myeloma","author":"Tricot","year":"2003","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood-2003-04-1045","article-title":"Treatment of multiple myeloma","volume":"103","author":"Crowley","year":"2004","journal-title":"Blood"},{"key":"3","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1158\/1535-7163.MCT-11-0433","article-title":"Mechanism of action of proteasome inhibitors and deacetylase inhibitors and the biological basis of synergy in multiple myeloma","volume":"10","author":"Anderson","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"4","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm0302-282","article-title":"Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound","volume":"8","author":"Selivanova","year":"2002","journal-title":"Nat Med"},{"key":"5","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/onc.2009.425","article-title":"Mutant p53 reactivation by PRIMA-1induces multiple signaling pathways converging on apoptosis","volume":"29","author":"Bykov","year":"2010","journal-title":"Oncogene"},{"key":"6","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1038\/onc.2010.382","article-title":"PRIMA-1(MET)\/APR-246 targets mutant forms of p53 family members p63 and p73","volume":"29","author":"Wilhelm","year":"2010","journal-title":"Oncogene"},{"key":"7","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1158\/1078-0432.CCR-10-3168","article-title":"PRIMA-1Met\/APR-246 induces apoptosis and tumor growth delay in small cell lung cancer expressing mutant p53","volume":"17","author":"Poulsen","year":"2011","journal-title":"Clin Cancer Res"},{"key":"8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1365-2141.2005.05851.x","article-title":"PRIMA-1 induces apoptosis in acute myeloid leukaemia cells with p53 gene deletion","volume":"132","author":"Paul","year":"2006","journal-title":"Br J Haematol"},{"key":"9","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1158\/1535-7163.MCT-12-1166","article-title":"PRIMA-1\/APR-246 displays high antitumor activity in multiple myeloma by induction of p73 and Noxa","volume":"12","author":"Chang","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1182\/blood-2014-01-548800","article-title":"PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH\/ROS balance","volume":"124","author":"Pellat-Deceunynck","year":"2014","journal-title":"Blood"},{"key":"11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism,, function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"12","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","article-title":"microRNAs as oncogenes and tumor suppressors","volume":"302","author":"Anderson","year":"2007","journal-title":"Dev Biol"},{"key":"14","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2174\/156800912802429355","article-title":"Promises and challenges of MicroRNA-based treatment of multiple myeloma","volume":"12","author":"Tassone","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"key":"15","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1158\/1078-0432.CCR-14-1437","article-title":"miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma","volume":"21","author":"Chang","year":"2015","journal-title":"Clin Cancer Res"},{"key":"16","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1200\/JCO.2011.40.7783","article-title":"Targeting p53: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancer","volume":"30","author":"Andersson","year":"2012","journal-title":"J Clin Oncol"},{"key":"17","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4161\/cbt.9.11.11882","article-title":"MDM2 antagonist nutlin plus proteasome inhibitor velcade combination displays a synergistic anti-myeloma activity","volume":"9","author":"Chang","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"18","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1182\/blood-2011-08-371567","article-title":"Addiction to c-MYC in multiple myeloma","volume":"120","author":"Sundan","year":"2012","journal-title":"Blood"},{"key":"19","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ccr.2012.09.003","article-title":"Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas","volume":"22","author":"Sotomayor","year":"2012","journal-title":"Cancer Cell"},{"key":"20","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/jcb.22630","article-title":"Transcriptional suppression of mir-29b-1\/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB","volume":"110","author":"Fernandez-Zapico","year":"2010","journal-title":"J Cell Biochem"},{"key":"21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/ejh.12124","article-title":"Aberrant microRNA expression in multiple myeloma","volume":"91","author":"Gronbaek","year":"2013","journal-title":"Eur J Haematol"},{"key":"22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrd4140","article-title":"MicroRNAs and other non-coding RNAs as targets for anticancer drug development","volume":"12","author":"Calin","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"23","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1038\/bcj.2012.31","article-title":"Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a\/CDK5 driven sensitivity)?","volume":"2","author":"Lawrie","year":"2012","journal-title":"Blood Cancer J"},{"key":"24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ng.2007.30","article-title":"Widespread microRNA repression by Myc contributes to tumorigenesis","volume":"40","author":"Mendell","year":"2008","journal-title":"Nat Genet"},{"key":"25","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/leu.2011.53","article-title":"Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma","volume":"25","author":"Fonseca","year":"2011","journal-title":"Leukemia"},{"key":"26","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/1477-3163.90437","article-title":"Cyclin D1 inhibits whereas c-Myc enhances the cytotoxicity of cisplatin in mouse pancreatic cancer cells via regulation of several members of the NF-kappaB and Bcl-2 families","volume":"10","author":"Liao","year":"2011","journal-title":"J Carcinog"},{"key":"27","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.1038\/onc.2008.312","article-title":"Apoptotic signaling by c-MYC","volume":"27","author":"Liebermann","year":"2008","journal-title":"Oncogene"},{"key":"28","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/leu.2015.10","article-title":"CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma","volume":"29","author":"Shortt","year":"2015","journal-title":"Leukemia"},{"key":"29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs - microRNAs with a role in cancer","volume":"6","author":"Slack","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbrc.2011.09.063","article-title":"Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1","volume":"414","author":"Wang","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"31","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1182\/blood-2010-09-301994","article-title":"MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression","volume":"117","author":"Lamant","year":"2011","journal-title":"Blood"},{"key":"32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2162-3619-3-17","article-title":"Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia","volume":"3","author":"Li","year":"2014","journal-title":"Exp Hematol Oncol"},{"key":"33","doi-asserted-by":"crossref","first-page":"e436","DOI":"10.1038\/cddis.2012.175","article-title":"miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1","volume":"3","author":"Neri","year":"2012","journal-title":"Cell Death Dis"},{"key":"34","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/mt.2011.48","article-title":"Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice","volume":"19","author":"Slack","year":"2011","journal-title":"Mol Ther"},{"key":"35","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1158\/1078-0432.CCR-12-1708","article-title":"Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma:andevidence","volume":"18","author":"Shammas","year":"2012","journal-title":"Clin Cancer Res"},{"key":"36","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.18632\/oncotarget.675","article-title":"DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma","volume":"3","author":"Tassone","year":"2012","journal-title":"Oncotarget"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6880","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T17:35:23Z","timestamp":1589218523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,11]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,2,9]]}},"alternative-id":["6880","26771839"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.6880","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,11]]}}}